Bluebird Bio Price Patterns

BLUEDelisted Stock  USD 4.97  0.23  4.85%   
The value of RSI of Bluebird Bio's stock price is about 64 suggesting that the stock is rather overbought by investors at the present time. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Bluebird, making its price go up or down.

Momentum 64

 Buy Extended

 
Oversold
 
Overbought
The successful prediction of Bluebird Bio's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Bluebird Bio and does not consider all of the tangible or intangible factors available from Bluebird Bio's fundamental data. We analyze noise-free headlines and recent hype associated with Bluebird Bio, which may create opportunities for some arbitrage if properly timed.
Using Bluebird Bio hype-based prediction, you can estimate the value of Bluebird Bio from the perspective of Bluebird Bio response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Bluebird Bio to buy its stock at a price that has no basis in reality. In that case, they are not buying Bluebird because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Bluebird Bio after-hype prediction price

    
  USD 4.97  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bluebird Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
3.933.935.47
Details
Naive
Forecast
LowNextHigh
4.684.684.68
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
4.954.985.00
Details

Bluebird Bio After-Hype Price Density Analysis

As far as predicting the price of Bluebird Bio at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Bluebird Bio or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Bluebird Bio, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Bluebird Bio Estimiated After-Hype Price Volatility

In the context of predicting Bluebird Bio's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Bluebird Bio's historical news coverage. Bluebird Bio's after-hype downside and upside margins for the prediction period are 4.97 and 4.97, respectively. We have considered Bluebird Bio's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
4.97
4.97
After-hype Price
4.97
Upside
Bluebird Bio is very steady at this time. Analysis and calculation of next after-hype price of Bluebird Bio is based on 3 months time horizon.

Bluebird Bio Stock Price Outlook Analysis

Have you ever been surprised when a price of a Company such as Bluebird Bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Bluebird Bio backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Bluebird Bio, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.00  
0.00
 0.00  
 0.00  
8 Events / Month
3 Events / Month
In about 8 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
4.97
4.97
0.00 
0.00  
Notes

Bluebird Bio Hype Timeline

Bluebird Bio is currently traded for 4.97. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Bluebird is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on Bluebird Bio is about 0.0%, with the expected price after the next announcement by competition of 4.97. About 40.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.73. Some equities with similar Price to Book (P/B) outperform the market in the long run. Bluebird Bio has Price/Earnings To Growth (PEG) ratio of 0.32. The entity recorded a loss per share of 20.59. The firm had not issued any dividends in recent years. Bluebird Bio had 1:20 split on the 13th of December 2024. Given the investment horizon of 90 days the next anticipated press release will be in about 8 days.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

Bluebird Bio Related Hype Analysis

Having access to credible news sources related to Bluebird Bio's direct competition is more important than ever and may enhance your ability to predict Bluebird Bio's future price movements. Getting to know how Bluebird Bio's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Bluebird Bio may potentially react to the hype associated with one of its peers.

Bluebird Bio Additional Predictive Modules

Most predictive techniques to examine Bluebird price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Bluebird using various technical indicators. When you analyze Bluebird charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Bluebird Bio Predictive Indicators

The successful prediction of Bluebird Bio stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Bluebird Bio, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Bluebird Bio based on analysis of Bluebird Bio hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Bluebird Bio's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Bluebird Bio's related companies.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Consideration for investing in Bluebird Stock

If you are still planning to invest in Bluebird Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bluebird Bio's history and understand the potential risks before investing.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like